NOF Corporation
TTSE:44032,822.00
JPY
-1.50
(-0.05%)
ISIN
JP3753400005
Return %
Stock
S&P 500
1Y
3.90
14.20
3Y
40.96
81.12
5Y
50.64
68.34
Capital Structure
JPY
•
in mil. unless spec.Working Capital
JPY
•
in mil. unless spec.Growth Rates
JPY
•
in mil. unless spec.Quarterly Revenue
JPY
•
in mil. unless spec.Quarterly Earnings Per Share
JPY
•
in mil. unless spec.Quarterly Dividends Per Share
JPY
•
in mil. unless spec.Company Description
- CEO
- Koji Sawamura
- Full Time Employees
- 4,155
- Sector
- Process industries
- Industry
- Chemicals: specialty
- Address
- Yebisu Garden Place Tower Tokyo TY Japan 150-6012
- IPO Date
- Sep 1, 1949
- Website
- nof.co.jp
- Similar Companies
- Business
- NOF Corporation, a diversified chemical manufacturer founded in 1937 and headquartered at Yebisu Garden Place Tower in Tokyo, Japan, engages in the development and production of functional materials, life science products, explosives and propulsion systems, and functional foods across Japan, North America, Europe, Southeast Asia, and China. The company operates through three primary segments offering fatty acids and derivatives, surfactants, ethylene oxide and propylene oxide derivatives, organic peroxides, functional polymers, functional films, petrochemical products, electronic materials, special corrosion prevention agents, edible oils, functional foods, activated PEG, functional lipids, surfactants for drugs, biocompatible materials, plant-derived ingredients, MPC polymers and monomers, industrial explosives, solid propellants, pyrotechnic devices, gun propellants, rocket propellants, guided missile assemblies, anti-freezing agents, and temperature and sterilization indicators; it also provides drug delivery solutions including linear and branched hetero-activated PEGs, single molecule PEG linkers for antibody drug conjugates, phospholipids nanoparticle formulations, SS-cleavable lipids such as the proprietary COATSOME SS-Series for nucleic acid and gene delivery, and ultra-purity Polysorbates 80 for antibody derivatives. Geographically, NOF maintains key production sites including the Daishi Plant, Oita Works, Aichi Works, and Tsukuba research facilities in Japan, alongside subsidiaries like NOF Metal Coatings North America Inc., NOF Europe GmbH, PT. NOF MAS Chemical Industries in Indonesia, and Changshu NOF Chemical Co., Ltd. in China. Recent developments include the 2024 strategic investment as a minority shareholder in Phosphorex LLC to enhance cGMP capabilities in nanoparticle-based drug delivery and strengthen its position in lipid nanoparticle technologies; the April 2024 acquisition of Hokkaido NOF Corporation by subsidiary Nippon Koki Co., Ltd.; the June 2024 establishment of new Oita Works with LS Oita Plant and LS Aichi Plant; and the April 2023 reorganization consolidating the Oleo & Specialty Chemicals and Functional Chemicals & Polymers divisions into Functional Materials, alongside merging Life Science Products and DDS Development into the Life Science Division.